Discover a study that examined the efficacy and safety of pemafibrate in 360 patients with MASLD and hypertriglyceridaemia.

Denifanstat treatment significantly improves liver disease activity among individuals with metabolic dysfunction-associated steatohepatitis.

RAMAT GAN, Israel, Dec. 04, 2024 (GLOBE NEWSWIRE) -- (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a ...

Your liver is a hardworking organ that performs hundreds of vital functions, from filtering toxins out of your blood to ...

Recently, claims have surfaced suggesting that acupuncture techniques can improve fatty liver. But are these claims valid? Is ...